Clinical trial Recruiting at 1 site Observational Ages 1 Week to 100

Genetic investigation of Hirschsprung disease

Official title: Genetic Analysis of Hirschsprung Disease

Run by NYU Langone Health · NCT00478712 · Data updated 2026-11-12

This study is trying to find out which genetic changes cause Hirschsprung disease by looking at the DNA of people with the condition and their close family members.

More Hirschsprung Disease trials

Quick facts

Study typeObservational
Ages1 Week to 100 Years
SexAll
Enrollment3000 (estimated)
SponsorNYU Langone Health
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedJanuary 2001
Main results expectedDecember 2028
Study endsDecember 2028
Registry record updatedJune 4, 2026
Trial IDNCT00478712 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with Hirschsprung disease and their first-degree relatives.

Probably not a fit

Patients who are unable or unwilling to provide genetic samples or cannot give informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on Hirschsprung disease, a genetic condition characterized by the absence of nerve cells in the intestines. The research aims to identify the genetic mutations responsible for this condition by utilizing whole genome mapping and sequencing techniques. It will also collect clinical data to explore the relationship between genetic variations and the clinical presentation of the disease. The study involves individuals with Hirschsprung disease and their first-degree relatives to better understand the inheritance patterns and potential genotype-phenotype correlations.

Why it matters

Potential benefit: If successful, this study could lead to improved genetic understanding and potential future therapies for Hirschsprung disease.

How similar studies have gone: Other studies investigating genetic factors in Hirschsprung disease have shown promise, indicating that this approach is supported by previous research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Individuals with Hirschsprung disease and their first degree relatives (any segment length of disease, with or without other congenital anomalies or health problems, single or multiple affected individuals in family)

Exclusion Criteria:

* Unable or unwilling to provide sample for genetic studies
* Individual, parent, or guardian unable to comprehend and provide informed consent

Where it's running

  • New York University School of Medicine
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.